Skip to main content

Obexelimab in IgG4-Related Disease: INDIGO Trial

Jun 24, 2026 10:00 am

Dr. Henrique Dalmolin reports on abstract OP018 from EULAR 2026.

ADD THE FIRST COMMENT

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.

×